Back to Explorer

Collecting and Providing 702(b) Portions of FDA Official Samples: Draft Guidance for Industry

DraftCenter for Drug Evaluation and Research Center for Veterinary Medicine Office of Inspections and Investigations Center for Biologics Evaluation and Research Human Foods Program01/01/2022

Description

This draft guidance is intended to assist FDA staff and industry with issues and questions related to the requirements for FDA to collect and provide portions of official samples under section 702(b) of the Federal Food, Drug, & Cosmetic Act (FD&C Act) and its implementing regulation in Title 21 Code of Federal Regulations (CFR) section 2.10 (21 CFR 2.10).  The contents of this document do not have the force and effect of law and are not meant to bind the public in any way, unless specifically incorporated into a contract. This document is intended only to provide clarity to the public regarding existing requirements under the law. FDA guidance documents, including this guidance, should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited. The use of the word should in Agency guidance means that something is suggested or recommended, but not required.

Scope & Applicability

Product Classes

8
Food

articles used for food or drink for man or other animals

Drug

Defined in section 201(g) of the FD&C Act; Articles intended for use in diagnosis, cure, mitigation, treatment, or prevention of disease; Product classification based on chemical action or specific intended uses like altering pH

Cosmetic

Subject to sampling requirements under 702(b).; Cosmetic means articles intended to be rubbed, poured, sprinkled, or sprayed on the human body

Dietary supplement

A dietary supplement is deemed to be food under section 201(ff)

Food additive

Legal classification of substances not GRAS and requiring approval.

Combination Product

Products combining drug, device, or biological constituents; Generally recommended for Enhanced Documentation; Requires 14971-based framework incorporating ICH Q9; A drug-device combination where the device constituent part detects ingestion.

Medical device

The general category of products this guidance applies to.

Tobacco product

Example of product not requiring a 702(b) portion

Stakeholders

6
Office of Regulatory Science

ORA office that may be consulted regarding sample portions.

Owner

Person whose actions may cause a product to be deemed adulterated

Commissioned state or local official

Officials who may collect official samples.

FDA investigator

HHS officer or employee who collects an official sample

Division Director of Compliance

The individual to whom the request for a 702(b) portion can be addressed.

Office of Chief Counsel

FDA office that may be consulted regarding requests for sample portions.

Regulatory Context

Attributes

1
perishable

Condition under which FDA is authorized to destroy a sample.

Related CFR Sections (1)

Collecting and Providing 702(b) Portions of FDA Official Samples: Draft Guidance for Industry | Guideline Explorer | BioRegHub